Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
3 August 2015 |
Main ID: |
NCT02499341 |
Date of registration:
|
12/07/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A Comparison Study Between Ketamine Versus Tramadol for Pain Management After Major Upper Abdominal Surgery
|
Scientific title:
|
Comparison Between Ketamine and Tramadol for Pain Management After Major Upper Abdominal Surgery |
Date of first enrolment:
|
July 2011 |
Target sample size:
|
42 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02499341 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Greece
| | | | | | | |
Contacts
|
Name:
|
Paraskevi Matsota, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Attikon University Hospital, Athens, Greece |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age between 18 and 70 years
- American Society of Anesthesiologists (ASA) physical status I and II
- Major Upper abdominal Surgery (Elective Hepatectomy, Gastrectomy, Whipple procedure,
Peripheral Pancreatectomy)
Exclusion Criteria:
- Patient's refusal to participate in the study
- Performance of regional anaesthesia
- Unsuitability for Patient Controlled Analgesia
- Current opiates use
- Drug addiction
- Chronic Pain Syndromes
- Alcohol addiction
- Epilepsy
- Psychiatric disorders
- Use of Monoamine Oxidase Inhibitor or Selective Serotonin Reuptake Inhibitor
- Sleep Apnea Syndrome
- Extrapyramidal Syndromes
- Severe liver, kidney or heart disease
- Known allergy to ketamine, tramadol or morphine.
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Postoperative Pain
|
Intervention(s)
|
Drug: Tramadol
|
Drug: Ketamine
|
Primary Outcome(s)
|
Measurement of morphine consumption expressed as milligrams postoperatively in abdominal surgery.
[Time Frame: 48 hours postoperatively]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|